Home
Calibr

Calibr Market Share Analysis for April 2026

Science and Education > Biology

Domaincalibr.org

Year Founded2012

Employees51 - 200

Annual Revenue--

Calibr

Calibr (including company regionals)

calibr.org

See more website traffic and engagement information

Total visits to Calibr's top domains

Understand Calibr market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Calibr's top domains

Analyze Calibr engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Calibr's top domains

See how Calibr keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Calibr top competitors by domain

Top similar sites in April 2026, ranked by their affinity

stratosgenomics.comCompany NameStratos GenomicsEmployees51 - 200HQUnited States, Washington, SeattleAnnual revenue$15M - $25MTotal visits--Science and Education > Biology

Top technologies used by Calibr

These are the website technologies, by industry, used by Calibr top domains

Content Management System (2)

Drupal

Conversion & Analytics (1)

Google Analytics

Email Services (1)

Microsoft Exchange Online

Mobile (1)

Meta Viewport

More Technologies

1

See all

News & Signals from Calibr

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsDeinove partners with Calibr.Deinove is also working with the non-profit drug discovery group Calibr to explore the anti-infectious potential of the Parisian firm's bacterial collection.

NewsCalibr partners with AbbVie.The sCAR-T platform technology was developed by Calibr, a division of Scripps Research, and a partnership with AbbVie has enabled this first-in-human trial.

NewsCalibr is developing T-cell therapies for the treatment of cancers on Jun 1st '18.In June 2018, AbbVie and Calibr, a non-profit drug discovery division of Scripps Research, collaborated to develop T-cell therapies for the treatment of cancers, which also includes solid tumors.